Back
Corcept Therapeutics Stock Predictions
Sponsored
CORT
Sponsored
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market
Buy
68
CORT
Corcept Therapeutics
Last Price:
40.92
Seasonality Move:
-0.77%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Corcept Therapeutics Stock Forecast
- Over the next 52 weeks, Corcept Therapeutics has on average historically risen by 28.4% based on the past 20 years of stock performance.
- Corcept Therapeutics has risen higher in 11 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 55%
-
Is Corcept Therapeutics Stock Undervalued?
The current Corcept Therapeutics [CORT] share price is $42.27. The Score for CORT is 68, which is 36% above its historic median score of 50, and infers lower risk than normal. - CORT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Corcept Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Corcept Therapeutics has on average historically risen by 28.4% based on the past 20 years of stock performance.
Corcept Therapeutics Stock Rating
Buy
68
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics overpriced?
- Corcept Therapeutics has risen higher in 11 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 55%
Corcept Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
corcept.com
52-Week Data
52-Week High:
43.32
52-Week Low:
20.84
Prediction Charts
Market Cap:
4.42B
Price in USD:
42.27
Volume:
1.99M
Beta:
0.85
Technical Analysis
SMA50:
34.88
SMA100:
32.01
SMA200:
28.43
52-Wk Change:
30.79%
Stock Predictions
-
Is Corcept Therapeutics stock public?
Yes, Corcept Therapeutics is a publicly traded company. -
What is the Corcept Therapeutics stock quote today?
The Corcept Therapeutics stock price is 42.27 USD today. -
How to buy Corcept Therapeutics stock online?
You can buy Corcept Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Aug-29 | 34.57 | 35.14 | 35.62 | 34.04 |
Aug-30 | 35.32 | 35.29 | 35.48 | 34.80 |
Sep-3 | 35.06 | 34.27 | 35.54 | 34.11 |
Sep-4 | 34.13 | 34.62 | 34.66 | 33.34 |
Sep-5 | 34.74 | 34.07 | 35.58 | 33.85 |
Sep-6 | 34.33 | 34.38 | 34.61 | 33.66 |
Sep-9 | 34.38 | 34.71 | 35.08 | 34.25 |
Sep-10 | 34.84 | 35.03 | 35.04 | 34.34 |
Sep-11 | 35.04 | 35.55 | 36.13 | 34.87 |
Sep-12 | 35.94 | 35.70 | 36.17 | 35.45 |
Sep-13 | 35.94 | 38.11 | 38.18 | 35.87 |
Sep-16 | 38.31 | 38.47 | 39.24 | 37.82 |
Sep-17 | 39.03 | 39.71 | 41.95 | 38.68 |
Sep-18 | 40.30 | 42.27 | 43.32 | 40.15 |
Corcept Therapeutics Earnings
Corcept Therapeutics Earnings Report: Per Share Corcept Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Corcept Therapeutics Forecast Revenue Growth
Corcept Therapeutics Stock Analysis: Historical quarterly revenues per share for Corcept Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.15 per share, an increase this year of $0.22 per share, and an increase next year of $0.59 per share.
* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.